FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2028049056> ?p ?o ?g. }

• W2028049056 endingPage "1109" @default.
• W2028049056 startingPage "1104" @default.
• W2028049056 abstract "Human bitter taste is mediated by the hTAS2R family of G protein-coupled receptors [1Adler E. Hoon M.A. Mueller K.L. Chandrashekar J. Ryba N.J.P. Zuker C.S. A novel family of mammalian taste receptors.Cell. 2000; 100: 693-702Abstract Full Text Full Text PDF PubMed Scopus (972) Google Scholar, 2Bufe B. Hofmann T. Krautwurst D. Raguse J.-D. Meyerhof W. The human TAS2R16 receptor mediates bitter taste in response to β-glucopyranosides.Nat. Genet. 2002; 32: 397-401Crossref PubMed Scopus (324) Google Scholar, 3Chandrashekar J. Mueller K.L. Hoon M.A. Adler E. Feng L. Guo W. Zuker C.S. Ryba N.J. T2Rs function as bitter taste receptors.Cell. 2000; 100: 703-711Abstract Full Text Full Text PDF PubMed Scopus (1012) Google Scholar, 4Matsunami H. Montmayeur J.P. Buck L.B. A family of candidate taste receptors in human and mouse.Nature. 2000; 404: 601-604Crossref PubMed Scopus (541) Google Scholar]. The discovery of the hTAS2Rs enables the potential to develop specific bitter receptor antagonists that could be beneficial as chemical probes to examine the role of bitter receptor function in gustatory and nongustatory tissues. In addition, they could have widespread utility in food and beverages fortified with vitamins, antioxidants, and other nutraceuticals, because many of these have unwanted bitter aftertastes. We employed a high-throughput screening approach to discover a novel bitter receptor antagonist (GIV3727) that inhibits activation of hTAS2R31 (formerly hTAS2R44) by saccharin and acesulfame K, two common artificial sweeteners. Pharmacological analyses revealed that GIV3727 likely acts as an orthosteric, insurmountable antagonist of hTAS2R31. Surprisingly, we also found that this compound could inhibit five additional hTAS2Rs, including the closely related receptor hTAS2R43. Molecular modeling and site-directed mutagenesis studies suggest that two residues in helix 7 are important for antagonist activity in hTAS2R31 and hTAS2R43. In human sensory trials, GIV3727 significantly reduced the bitterness associated with the two sulfonamide sweeteners, indicating that hTAS2R antagonists are active in vivo. Our results demonstrate that small molecule bitter receptor antagonists can effectively reduce the bitter taste qualities of foods, beverages, and pharmaceuticals." @default.
• W2028049056 created "2016-06-24" @default.
• W2028049056 creator A5004124509 @default.
• W2028049056 creator A5009872018 @default.
• W2028049056 creator A5024990714 @default.
• W2028049056 creator A5025695992 @default.
• W2028049056 creator A5025704473 @default.
• W2028049056 creator A5046738312 @default.
• W2028049056 creator A5047231532 @default.
• W2028049056 creator A5050522046 @default.
• W2028049056 creator A5052586591 @default.
• W2028049056 creator A5053220470 @default.
• W2028049056 creator A5059842265 @default.
• W2028049056 creator A5060248220 @default.
• W2028049056 creator A5061685157 @default.
• W2028049056 creator A5072404910 @default.
• W2028049056 creator A5076819232 @default.
• W2028049056 creator A5083531772 @default.
• W2028049056 creator A5086597877 @default.
• W2028049056 creator A5090020371 @default.
• W2028049056 date "2010-06-01" @default.
• W2028049056 modified "2023-10-14" @default.
• W2028049056 title "Modulation of Bitter Taste Perception by a Small Molecule hTAS2R Antagonist" @default.
• W2028049056 cites W1496676716 @default.
• W2028049056 cites W1825353903 @default.
• W2028049056 cites W1833104430 @default.
• W2028049056 cites W1975740938 @default.
• W2028049056 cites W1976005198 @default.
• W2028049056 cites W1978990274 @default.
• W2028049056 cites W1981479484 @default.
• W2028049056 cites W1983792789 @default.
• W2028049056 cites W1985101496 @default.
• W2028049056 cites W1986387206 @default.
• W2028049056 cites W1988097700 @default.
• W2028049056 cites W2032276066 @default.
• W2028049056 cites W2045358393 @default.
• W2028049056 cites W2046325265 @default.
• W2028049056 cites W2064034213 @default.
• W2028049056 cites W2071196106 @default.
• W2028049056 cites W2073115006 @default.
• W2028049056 cites W2089885047 @default.
• W2028049056 cites W2104477830 @default.
• W2028049056 cites W2126098900 @default.
• W2028049056 cites W2133838855 @default.
• W2028049056 cites W2137311570 @default.
• W2028049056 cites W2139177655 @default.
• W2028049056 cites W2144827439 @default.
• W2028049056 cites W2150501463 @default.
• W2028049056 cites W2164221127 @default.
• W2028049056 cites W2164440959 @default.
• W2028049056 cites W2169702025 @default.
• W2028049056 doi "https://doi.org/10.1016/j.cub.2010.04.043" @default.
• W2028049056 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2925244" @default.
• W2028049056 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20537538" @default.
• W2028049056 hasPublicationYear "2010" @default.
• W2028049056 type Work @default.
• W2028049056 sameAs 2028049056 @default.
• W2028049056 citedByCount "132" @default.
• W2028049056 countsByYear W20280490562012 @default.
• W2028049056 countsByYear W20280490562013 @default.
• W2028049056 countsByYear W20280490562014 @default.
• W2028049056 countsByYear W20280490562015 @default.
• W2028049056 countsByYear W20280490562016 @default.
• W2028049056 countsByYear W20280490562017 @default.
• W2028049056 countsByYear W20280490562018 @default.
• W2028049056 countsByYear W20280490562019 @default.
• W2028049056 countsByYear W20280490562020 @default.
• W2028049056 countsByYear W20280490562021 @default.
• W2028049056 countsByYear W20280490562022 @default.
• W2028049056 countsByYear W20280490562023 @default.
• W2028049056 crossrefType "journal-article" @default.
• W2028049056 hasAuthorship W2028049056A5004124509 @default.
• W2028049056 hasAuthorship W2028049056A5009872018 @default.
• W2028049056 hasAuthorship W2028049056A5024990714 @default.
• W2028049056 hasAuthorship W2028049056A5025695992 @default.
• W2028049056 hasAuthorship W2028049056A5025704473 @default.
• W2028049056 hasAuthorship W2028049056A5046738312 @default.
• W2028049056 hasAuthorship W2028049056A5047231532 @default.
• W2028049056 hasAuthorship W2028049056A5050522046 @default.
• W2028049056 hasAuthorship W2028049056A5052586591 @default.
• W2028049056 hasAuthorship W2028049056A5053220470 @default.
• W2028049056 hasAuthorship W2028049056A5059842265 @default.
• W2028049056 hasAuthorship W2028049056A5060248220 @default.
• W2028049056 hasAuthorship W2028049056A5061685157 @default.
• W2028049056 hasAuthorship W2028049056A5072404910 @default.
• W2028049056 hasAuthorship W2028049056A5076819232 @default.
• W2028049056 hasAuthorship W2028049056A5083531772 @default.
• W2028049056 hasAuthorship W2028049056A5086597877 @default.
• W2028049056 hasAuthorship W2028049056A5090020371 @default.
• W2028049056 hasBestOaLocation W20280490561 @default.
• W2028049056 hasConcept C170493617 @default.
• W2028049056 hasConcept C178006227 @default.
• W2028049056 hasConcept C2776885963 @default.
• W2028049056 hasConcept C2779473830 @default.
• W2028049056 hasConcept C3020017864 @default.
• W2028049056 hasConcept C38858142 @default.
• W2028049056 hasConcept C55493867 @default.
• W2028049056 hasConcept C83867959 @default.

• next